Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

For centuries, music has been a balm for the soul — and, it turns out, for the body as well. From ancient healing rituals to ...

For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

Vertex’s new drug Journavx (suzetrigine) has been hailed as a scientific breakthrough because it allays pain without entering the brain, minimizing the risk of addiction and dependence that can ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...

The Food and Drug Administration approved Vertex Pharmaceuticals’ “Journavx” on Thursday, greenlighting the non-opioid ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...